NCT06788002View on ClinicalTrials.gov

LDRT and Chemoimmunotherapy in NPC With Liver Metastasis

PHASE2RecruitingINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

January 14, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2027

Conditions
Nasopharyngeal Cancinoma (NPC)
Interventions
OTHER

Low-dose radiotherapy combine with chemoimmunotherapy

Radiation: 1.4Gy for 5 days to the liver metastasis before chemoimmunotherapy. Chemoimmunotherapy: gemcitabine(1000mg per square meter on days 1,8) , cisplatin (80mg per square meter on day 1), penpulimab (200mg, day1)

Trial Locations (7)

410000

RECRUITING

Qingnan Tang, Changsha

RECRUITING

Xiangya Hospital of Central South University, Changsha

410013

RECRUITING

Huai Liu, Changsha

RECRUITING

Hui Wang, Changsha

414020

RECRUITING

Jie Weng, Yueyang

422000

RECRUITING

Xinfu Liu, Shaoyang

424300

RECRUITING

Qiyuan Zhou, Chenzhou

All Listed Sponsors
lead

Hunan Cancer Hospital

OTHER